Research.Patient.info
Chronic Myeloid Leukemia research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE3
Study of Olverembatinib (HQP1351) in Patients With CML-CP
This study is looking at a new medicine called olverembatinib for people with a type of blood cancer called Chronic Myeloid Leukemia (CML-CP). It compares olverembatinib with an existing medicine, bosutinib, and also checks the new medicine for those with a specific gene change (T315I mutation).
United States · Australia · Belgium - recruitingPHASE1
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
This study is looking at a new medicine called ELVN-001 for people with a type of blood cancer called Chronic Myeloid Leukaemia (CML). It aims to find the right dose and see how safe and effective it is, especially for those who haven't responded well to other treatments.
United States · Australia · Belgium